SCHEMBL9926609

SCHEMBL9926609

CNc1nc(C)cnc1C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.33
CYP1A2 P05177 3/20 0.33
ALOX15 P16050 1/20 0.33
HSD17B10 Q99714 1/20 0.33
NOS3 P29474 1/20 0.32
NOS2 P35228 1/20 0.32
HPGD P15428 3/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
CYP2C19 P33261 2/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
METAP2 P50579 1/20 0.32
METAP1 P53582 1/20 0.32
CYP2D6 P10635 1/20 0.32
JAK3 P52333 1/20 0.32
PDPK1 O15530 1/20 0.31
POLB P06746 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
LRRK2 Q5S007 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17084504 0.81 JAK3 (0.35) CYP3A4CYP1A2ALOX15HSD17B10NOS3
SCHEMBL4634255 0.79 KDM4E (0.39) CYP3A4CYP1A2HPGDKDM4EALDH1A1
SCHEMBL26288121 0.77 PGK1 (0.39) CYP3A4CYP1A2HPGDKDM4EALDH1A1
SCHEMBL26288127 0.77 ALDH1A1 (0.41) CYP3A4CYP1A2ALOX15HSD17B10KDM4E
SCHEMBL25154084 0.74 PDCD1 (0.36) HSD17B10HPGDKDM4EALDH1A1MAPT
SCHEMBL26801021 0.74 CCR4 (0.46) CYP3A4CYP1A2HSD17B10ALDH1A1HTT
SCHEMBL21985368 0.73 GRM5 (0.34) CYP3A4CYP1A2NOS3NOS2KDM4E
SCHEMBL24457887 0.73 NOS3 (0.30) CYP3A4CYP1A2NOS3NOS2CYP2D6
SCHEMBL24600094 0.73 PDXK (0.34) LRRK2
SCHEMBL23889339 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023064345-A1 SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF VANQUA BIO, INC. (US) 2023-04-20 WO disclosed
EP-3318561-B1 HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC (US) 2021-12-22 EP disclosed
EP-2463714-A1 Basic compound, chemically amplified resist composition and patterning process Shin-Etsu Chemical Co., Ltd. (JP) 2012-06-13 EP disclosed